CV-4151 A POTENT, SELECTIVE THROMBOXANE-A2 SYNTHETASE INHIBITOR

被引:36
|
作者
TERASHITA, Z
IMURA, Y
TANABE, M
KAWAZOE, K
NISHIKAWA, K
KATO, K
TERAO, S
机构
[1] TAKEDA CHEM IND LTD,DIV CENT RES,YODOGAWA KU,OSAKA 532,JAPAN
[2] TAKEDA CHEM IND LTD,CHEM LABS,YODOGAWA KU,OSAKA 532,JAPAN
关键词
D O I
10.1016/0049-3848(86)90231-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:223 / 237
页数:15
相关论文
共 50 条
  • [1] ANTIANGINAL EFFECT OF CV-4151, A NEW, POTENT, SELECTIVE INHIBITOR OF THROMBOXANE SYNTHETASE
    KIMURA, Y
    KODAMA, K
    NAKA, M
    NANTO, S
    TANIURA, K
    KUZUYA, T
    HAMANAKA, Y
    TADA, M
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1986, 7 (02) : A177 - A177
  • [2] THE THROMBOXANE-A2 PROSTAGLANDIN ENDOPEROXIDE RECEPTOR ANTAGONIST ACTIVITY OF CV-4151, A THROMBOXANE-A2 SYNTHETASE INHIBITOR
    IMURA, Y
    TERASHITA, Z
    SHIBOUTA, Y
    NISHIKAWA, K
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 147 (03) : 359 - 365
  • [3] ANGIOSCOPIC STUDY OF THE ANTITHROMBOTIC EFFECT OF A NEW SELECTIVE THROMBOXANE-A2 SYNTHETASE INHIBITOR, CV-4151, ON EXPERIMENTAL ARTERIAL THROMBI
    MATSUBARA, T
    YAMAZOE, M
    TAMURA, Y
    IGARASHI, Y
    IZUMI, T
    SHIBATA, A
    AMERICAN HEART JOURNAL, 1989, 118 (04) : 837 - 839
  • [4] DELAY OF THE INITIATION OF HYPERTENSION IN SPONTANEOUSLY HYPERTENSIVE RATS BY CV-4151, A SPECIFIC THROMBOXANE-A2 SYNTHETASE INHIBITOR
    SHIBOUTA, Y
    TERASHITA, Z
    INADA, Y
    NISHIKAWA, K
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1985, 109 (02) : 135 - 144
  • [5] THE EFFECTS OF AN ORAL THROMBOXANE A2 SYNTHETASE INHIBITOR, CV-4151, IN MAN
    KUZUYA, T
    KODAMA, K
    HAMANAKA, Y
    KAMADA, T
    KIMURA, Y
    TANIURA, K
    NAKA, M
    TADA, M
    CIRCULATION, 1985, 72 (04) : 471 - 471
  • [6] CLINICAL-PHARMACOLOGY OF A NEW THROMBOXANE A2 SYNTHETASE INHIBITOR, CV-4151
    NAKAMURA, N
    TADA, M
    KODAMA, K
    ACTA PHARMACOLOGICA ET TOXICOLOGICA, 1986, 59 : 50 - 50
  • [7] THE EFFECT OF CV-4151, A SELECTIVE INHIBITOR OF THROMBOXANE SYNTHETASE, ON PROSTANOID FORMATION AND PLATELET-AGGREGATION IN HUMANS
    KUZUYA, T
    KIMURA, Y
    HOSHIDA, S
    KODAMA, K
    NAKAMURA, N
    HAMANAKA, Y
    KITABATAKE, A
    KAMADA, T
    TADA, M
    CARDIOVASCULAR DRUGS AND THERAPY, 1988, 2 (05) : 693 - 700
  • [8] EFFECTS OF THROMBOXANE-A(2) SYNTHETASE INHIBITOR (CV-4151) ON REPERFUSED SKELETAL-MUSCLE IN RATS
    SASAKI, Y
    ISHIGURO, N
    MIURA, T
    EUROPEAN SURGICAL RESEARCH, 1994, 26 (02) : 101 - 107
  • [9] EXPERIMENTAL-MODEL OF CHRONIC RENAL-ALLOGRAFT REJECTION IN RATS AND THERAPEUTIC EFFICACY OF A NEW SELECTIVE THROMBOXANE-A2 (TXA2) SYNTHETASE INHIBITOR (CV-4151)
    TANABE, K
    TOMA, H
    SAGARA, R
    TAKAHASHI, K
    TERAOKA, S
    OTA, K
    TRANSPLANTATION PROCEEDINGS, 1989, 21 (01) : 293 - 295
  • [10] ANTAGONISM OF COLLAGEN-INDUCED ECG-CHANGES IN RATS BY A THROMBOXANE SYNTHETASE INHIBITOR, CV-4151
    MATSUMURA, H
    TERASHITA, Z
    NISHIKAWA, K
    IMAI, Y
    FOLIA PHARMACOLOGICA JAPONICA, 1986, 87 (04) : 397 - 404